(Reuters) - German drugmaker Boehringer Ingelheim said it would pay about $650 million to settle U.S. lawsuits that claimed the company's blockbuster blood thinner Pradaxa had caused severe and fatal bleeding in patients. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/GFdD2JxVBjY/story01.htm
Read More
No comments:
Post a Comment